UK markets open in 3 hours
NIKKEI 225
38,264.58 -9.47 (-0.02%) HANG SENG
18,109.76 +346.73 (+1.95%) CRUDE OIL
79.44 +0.44 (+0.56%) GOLD FUTURES
2,327.80 +16.80 (+0.73%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,848.34 -2,176.21 (-4.53%)
Heron Therapeutics, Inc. (0J4V.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 05:34PM BST
| Previous close | 2.5186 |
| Open | 0.0000 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.0000 - 0.0000 |
| 52-week range | |
| Volume | |
| Avg. volume | 12,412 |
| Market cap | 1.884M |
| Beta (5Y monthly) | 1.71 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.2930 |
| Earnings date | 07 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksWill Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know
Heron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Simply Wall St.Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Profit Outlook
With the business potentially at an important milestone, we thought we'd take a closer look at Heron Therapeutics...
PR NewswireHeron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company will host a conference call and live webcast on Tuesday, May 7, 2024, at 8:30 a.m. ET to report first quarter 2024 financial results and discuss recent business highlights.
© 2024 Yahoo. All rights reserved.